Pharmafile Logo

Cyan Group

Cyan Group unites every stage of the communications lifecycle in a single solution so you can execute campaigns faster than ever before. We believe only through understanding the entire supply chain from creative through to delivery, can real consistency, control and effective communication be achieved. Giving you greater control to personalise your campaigns, tailoring the communications channel whilst significantly increasing your return on investment.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

5th Floor, Regal House, London Road, Twickenham, Middx, TW1 3QS, United Kingdom
+44 (0)20 88438600

 Latest Content from PMHub 

You know more about your audience than you think

Our Digital Lead, Richard Springham, discusses the untapped resources of your digital tools and how they hold the key to targeting your audiences.

How will the NHS’s new medicines savings drive affect pharma?

Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets

Pharma need to keep their ‘pull & push’ separate from their ‘inbound & outbound’

Is your pharma brand using the marketing terms ‘pull & push’ correctly?

A man walks into a surgery: The role of storytelling in pharma marketing

Communicating through stories can make your brand messages more meaningful, memorable and persuasive

Embracing the demands of the empowered ‘consumer-savvy’ patient by Ann Generlich

Our access to information, which is now constantly at our fingertips and the explosion of new technologies has shifted the buying power to increasingly ‘consumer-savvy’ patients. These are patients who choose...

The Art of Agile Marketing

The industry knows that it needs become more responsive to its stakeholders. An agile approach – which quickly improves results through a process of rapid market feedback and response –...

Could ketamine be the next big thing in depression?

Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.

Attracting doctors to low-demand specialties: A role for industry?

 One of the major problems that healthcare systems around the world face is a paucity of medically qualified staff entering particular specialties and subspecialties. This can be due to a...

Men vs Women in emerging markets

Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS

South Korea: The next global player?

In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two...